Atrás
Precio Mymetics Corp (MYMX)
Gráfico del Precio de Acciones MYMX
MYMX Ganando
Mymetics Corp
$0
0%
$0
Al cierre: Feb 11, 16:00:00 GMT-5
$0
0%
$0
Mercado Posterior: Feb 11, 20:00:00 GMT-5
Sin datos aúnEarnings FAQ
¿Cómo se comparó el EPS reciente de MYMX con las expectativas?
¿Cómo fue el desempeño de los ingresos de Mymetics Corp MYMX en el último trimestre?
¿Cuál es la estimación de ingresos para Mymetics Corp?
¿Cuál es la puntuación de calidad de ganancias de Mymetics Corp?
¿Cuándo informa Mymetics Corp sus ganancias?
¿Cuáles son las ganancias esperadas de Mymetics Corp?
¿Superó Mymetics Corp las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.0003
Precio de apertura
$0.0003
Rango del día
$0.0003 - $0.0003
Rango de 52 semanas
$0.0003 - $0.001
Volumen
100
Volumen promedio
2
EPS (TTM)
-70.19
Rendimiento de dividendos
--
Cap. de mercado
$45.000001499999996
¿Qué es MYMX?
Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. The company is headquartered in Epalinges, Vaud and currently employs 8 full-time employees. The firm is focused on developing vaccines for infectious diseases. The firm has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.
Características
© 2025 Finture Development Limited. All rights reserved